-
www.ahrq.gov/hai/patient-safety-resources/cdiff-toolkit/cdiffl2tools2g.html
September 01, 2012 - Formulary changes, restrictions, and preauthorization
Number of calls/requests for restricted drug … number of courses or patients on restricted antibiotics, alternative antibiotics to the restricted drug
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/medicaidreadmitguide/mcaidread_tool10_dc_checklist.docx
November 01, 2015 - .*
Drug allergies and drug intolerances.*
8.
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/decision/mcc/mcfarland_r21grant.pdf
September 01, 2013 - Treatment Episode
Data Set, the National Survey of
Substance Abuse Treatment
Services, the Alcohol and Drug … Services Study, and the National
Survey on Drug Use and Health.
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/quality-resources/tools/literacy-toolkit/healthlittoolkit2-tool8b.docx
October 07, 2015 - Duplicate medicines
|_| Expired medicines
|_| Patient had contraindications for one or more medicines
|_| Drug-drug
-
www.ahrq.gov/news/newsroom/case-studies/index.html?page=46
August 01, 2005 - Oregon Date: August 2005
Pharmacy Association Uses AHRQ Module to Teach Patients About Adverse Drug … Impact Case Study Identifier: COE-05-06 AHRQ Product(s): CERTs Topic(s): Patient Safety, Adverse Drug
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-228-tables-1-2.pdf
February 12, 2018 - hypotension) < 5th percentile for age or systolic BP
< 2 SD below normal for age OR
• Need for vasoactive drug
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-229-section-1-tables-1-2.pdf
February 09, 2018 - ) < 5th percentile for age or systolic BP < 2
SD below normal for age
OR
• Need for vasoactive drug
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0231-section-1-tables-1-2.pdf
April 26, 2018 - hypotension) < 5th percentile for age or systolic BP < 2 SD below normal for
age OR
• Need for vasoactive drug
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/decision/mcc/grembowski_r21grant.pdf
September 01, 2013 - Statins and ACE Inhibitors in Adults with Diabetes and Comorbid Conditions
Comparative Effectiveness Research to Optimize Prevention and
Healthcare Management for the Complex Patient – R21 Grants
Statins and ACE Inhibitors in Adults with
Diabetes and Comorbid Conditions
Principal Investigator: David E. Grem…
-
www.ahrq.gov/sites/default/files/wysiwyg/chain/practice-tools/warfarin-1-slides.pdf
March 19, 2017 - Coumadin)
• Very commonly used drug in nursing homes
residents
• Goal of warfarin therapy: thin … blood so it will not clot
Warfarin, also known as Coumadin®, is a commonly used drug in older … Slide 4
Warfarin, also known as Coumadin®, is a commonly used drug in older patients,
especially … survival reassured the medical community about the safety
of warfarin, and physicians began to use this drug … Later that day, the nurse received a callback from a covering physician who prescribed
Bactrim, a drug
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol2/Layde.pdf
January 01, 2003 - systems are voluntary and most focus on
relatively few types of reportable events, such as adverse drug … discharges
Mean excess
LOS (days)*
Percent
increased
LOS*
Cumulative
excess
LOS**
Drug … complications 538 1.0 N/A†
Specific reaction to unknown drug 1,316 2.4 1.43***
Misc. comp due to … unspecified drugs 2,923 5.2 0.02**
All drug-related injuries 31,382 56.2 0.47**
DEVICE, IMPLANT, … In addition, it can be used to target certain
patient safety problems such as drug reactions and device
-
www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/ambulatory-care/respiratory-one-pager.pdf
September 01, 2022 - Food & Drug
Administration. February 2018.
-
www.ahrq.gov/news/newsroom/case-studies/cp30501.html
October 01, 2014 - Specifically, the research illustrated that when drug coverage caps were in effect for adult schizophrenic
-
www.ahrq.gov/news/newsroom/case-studies/cp30609.html
October 01, 2014 - Michigan State Uses Task Force Recommendations in Health Promotion Program for University Employees
Search All Impact Case Studies
June 2006
Michigan State University (MSU) utilizes the United States Preventive Services Task Force (USPSTF) recommendations in two ways in its campus health promotion program a…
-
www.ahrq.gov/chain/practice-tools/practice-guidelines/new-guidelines-for-treating-maladaptive-aggression-in-youth.html
March 01, 2017 - Food and Drug Administration (FDA) for prescribing antipsychotic medications since there are limited
-
www.ahrq.gov/chain/practice-tools/behavioral-mental-health/new-guidelines-for-treating-maladaptive-aggression-in-youth.html
March 01, 2017 - Food and Drug Administration (FDA) for prescribing antipsychotic medications since there are limited
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/Nemeth.pdf
January 01, 2002 - Food and Drug Administration (FDA) incident reports and field studies. … mode at the left side of the
interface allows direct entry of information, such as fluid volume and drug … Unlike dopamine, nesiritide and its stock,
concentrations are not in the pump drug library. … e) Change the same pump to deliver a premix of the drug nesiritide at a rate of 1
mcg/kg/min (a higher … Cook, et al.8 and Cook and Woods9 provide examples of
adverse drug infusion incidents involving these
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-228-detailed_measure-specs.pdf
August 01, 2014 - ) < 5th percentile for age or systolic BP
< 2 SD below normal for age
OR
• Need for vasoactive drug
-
www.ahrq.gov/sites/default/files/wysiwyg/nhguide/6_TK1_T2-Talking_with_Residents_Family_Members_Final.docx
October 01, 2016 - · Is this drug likely to cause any side effects? … · Does this drug interfere with the effectiveness of other medications? … Food and Drug Administration at http://www.fda.gov/Drugs/ResourcesForYou/
Consumers/BuyingUsingMedicineSafely
-
www.ahrq.gov/news/blog/ahrqviews/opioid-5-point-strategy.html
February 01, 2018 - health departments, or other community organizations gain access to naloxone, a potentially life-saving drug